Perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study
- PMID: 24932337
- PMCID: PMC4048699
- DOI: 10.11604/pamj.2014.17.26.2641
Perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings: a qualitative study
Abstract
Introduction: Isoniazid preventive therapy (IPT) reduces the risk of active TB. IPT is a key public health intervention for the prevention of TB among people living with HIV and has been recommended as part of a comprehensive HIV and AIDS care strategy. However, its implementation has been very slow and has been impeded by several barriers.
Objective: The Objective of the study is to assess the perceived barriers to the implementation of Isoniazid preventive therapy for people living with HIV in resource constrained settings in Addis Ababa, Ethiopia in 2010.
Methods: A qualitative study using a semi-structured interviewed guide was used for the in-depth interview. A total of 12 key informants including ART Nurse, counselors and coordinators found in four hospitals were included in the interview. Each session of the in-depth interview was recorded via audio tape and detailed notes. The interview was transcribed verbatim. The data was analyzed manually.
Results: The findings revealed that poor patient adherence was a major factor; with the following issues cited as the reasons for poor adherence; forgetfulness; lack of understanding of condition and patient non- disclosure of HIV sero-status leading to insubstantial social support; underlying mental health issues resulting in missed or irregular patient appointments; weak patient/healthcare provider relationship due to limited quality interaction; lack of patient information, patient empowerment and proper counseling on IPT; and the deficient reinforcement by health officials and other stakeholders on the significance of IPT medication adherence as a critical for positive health outcomes.
Conclusion: Uptake of the implementation of IPT is facing a challenge in resource limited settings. This recalled provision of training/capacity building and awareness creation mechanism for the health workers, facilitating disclosure and social support for the patients is recommended.
Keywords: Isoniazid preventive therapy; People Living with HIV; TB.
Similar articles
-
"It's about my life": facilitators of and barriers to isoniazid preventive therapy completion among people living with HIV in rural South Africa.AIDS Care. 2017 Jul;29(7):936-942. doi: 10.1080/09540121.2017.1283390. Epub 2017 Feb 1. AIDS Care. 2017. PMID: 28147705 Free PMC article.
-
Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study.BMC Public Health. 2016 Aug 19;16(1):840. doi: 10.1186/s12889-016-3525-8. BMC Public Health. 2016. PMID: 27543096 Free PMC article.
-
Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.BMC Infect Dis. 2017 Jan 3;17(1):5. doi: 10.1186/s12879-016-2109-7. BMC Infect Dis. 2017. PMID: 28049455 Free PMC article.
-
Use of isoniazid preventive therapy for tuberculosis prophylaxis among people living with HIV/AIDS: a review of the literature.J Acquir Immune Defic Syndr. 2015 Apr 15;68 Suppl 3(Suppl 3):S297-305. doi: 10.1097/QAI.0000000000000497. J Acquir Immune Defic Syndr. 2015. PMID: 25768869 Free PMC article. Review.
-
Mixed methods systematic review and metasummary about barriers and facilitators for the implementation of cotrimoxazole and isoniazid-Preventive therapies for people living with HIV.PLoS One. 2022 Mar 1;17(3):e0251612. doi: 10.1371/journal.pone.0251612. eCollection 2022. PLoS One. 2022. PMID: 35231047 Free PMC article.
Cited by
-
Completion of isoniazid-rifapentine (3HP) for tuberculosis prevention among people living with HIV: Interim analysis of a hybrid type 3 effectiveness-implementation randomized trial.PLoS Med. 2021 Dec 16;18(12):e1003875. doi: 10.1371/journal.pmed.1003875. eCollection 2021 Dec. PLoS Med. 2021. PMID: 34914696 Free PMC article. Clinical Trial.
-
Knowledge, Beliefs, and Perceptions of TB and Its Treatment amongst TB Patients in the Limpopo Province, South Africa.Int J Environ Res Public Health. 2021 Oct 2;18(19):10404. doi: 10.3390/ijerph181910404. Int J Environ Res Public Health. 2021. PMID: 34639702 Free PMC article.
-
Factors associated with isoniazid preventive treatment interruption and completion among PLHIV in Gombe Hospital, Uganda, 2017-2019.J Clin Tuberc Other Mycobact Dis. 2023 Jan 24;31:100349. doi: 10.1016/j.jctube.2023.100349. eCollection 2023 May. J Clin Tuberc Other Mycobact Dis. 2023. PMID: 37181458 Free PMC article.
-
Evaluation of the uptake of tuberculosis preventative therapy for people living with HIV in Namibia: a multiple methods analysis.BMC Public Health. 2020 Dec 1;20(1):1838. doi: 10.1186/s12889-020-09902-z. BMC Public Health. 2020. PMID: 33261569 Free PMC article.
-
Inequality in uptake of isoniazid prevention therapy and Mantoux test among pregnant women with HIV in the Eastern Cape, South Africa.BMC Public Health. 2019 Oct 29;19(1):1407. doi: 10.1186/s12889-019-7769-y. BMC Public Health. 2019. PMID: 31664978 Free PMC article.
References
-
- WHO. Geneva, Switzerland: World Health Organization; 2010. Global tuberculosis control: a short update to the 2010 Report.
-
- Corbett EL, Watt C, Walker N, Maher D, Williams BG, Raviglione MC. The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med. 2003;163(9):1009–1021. - PubMed
-
- Selwyn PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, Walker AT, Friedland GH. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320(9):545–550. - PubMed
-
- UNAIDS. Geneva: UNAIDS; 1998. Feb 18-20, Policy statement on preventive therapy against tuberculosis in people living with HIV.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical